HK1203823A1 - Method of treating diabetes using non-glycosylated apolipoprotein a- iv a-iv - Google Patents
Method of treating diabetes using non-glycosylated apolipoprotein a- iv a-ivInfo
- Publication number
- HK1203823A1 HK1203823A1 HK15104317.1A HK15104317A HK1203823A1 HK 1203823 A1 HK1203823 A1 HK 1203823A1 HK 15104317 A HK15104317 A HK 15104317A HK 1203823 A1 HK1203823 A1 HK 1203823A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treating diabetes
- glycosylated apolipoprotein
- apolipoprotein
- glycosylated
- diabetes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2012/021802 WO2012100010A1 (en) | 2011-01-19 | 2012-01-19 | Apolipoprotein aiv as an antidiabetic peptide |
US201261675692P | 2012-07-25 | 2012-07-25 | |
PCT/US2012/066314 WO2013109342A1 (en) | 2012-01-19 | 2012-11-21 | Method of treating diabetes using non-glycosylated apolipoprotein a-iv |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1203823A1 true HK1203823A1 (en) | 2015-11-06 |
Family
ID=48799573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15104317.1A HK1203823A1 (en) | 2012-01-19 | 2015-05-06 | Method of treating diabetes using non-glycosylated apolipoprotein a- iv a-iv |
Country Status (13)
Country | Link |
---|---|
US (1) | US9951120B2 (ja) |
EP (1) | EP2804618B1 (ja) |
JP (1) | JP6310398B2 (ja) |
KR (1) | KR20140117565A (ja) |
CN (1) | CN104066436B (ja) |
AU (1) | AU2012366182B2 (ja) |
BR (1) | BR112014017141A2 (ja) |
CA (1) | CA2860782A1 (ja) |
EA (1) | EA028230B1 (ja) |
HK (1) | HK1203823A1 (ja) |
IL (1) | IL233351A (ja) |
MX (1) | MX357071B (ja) |
WO (1) | WO2013109342A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9051394B2 (en) | 2011-01-19 | 2015-06-09 | University Of Cincinnati | Apolipoprotein AIV as an antidiabetic peptide |
JP6310398B2 (ja) | 2012-01-19 | 2018-04-11 | ユニバーシティ・オブ・シンシナティ | 非グリコシル化アポリポタンパク質a−ivを用いて糖尿病を処置する方法 |
US10232019B2 (en) | 2012-07-25 | 2019-03-19 | University Of Cincinnati | Method of treating hyperglycemic disorders using apolipoprotein AIV |
US9730980B2 (en) | 2012-07-25 | 2017-08-15 | University Of Cincinnati | Method of treating type I diabetes using apolipoprotein A-IV |
JP6629725B2 (ja) * | 2014-06-23 | 2020-01-15 | 東亞合成株式会社 | 新規合成ペプチドおよびその利用 |
CN112546201A (zh) * | 2019-09-26 | 2021-03-26 | 中国科学院生物物理研究所 | 人工脂蛋白颗粒apoA-Ⅳ脂肪体在治疗和/或预防糖尿病中的应用 |
CN112891561A (zh) * | 2021-03-09 | 2021-06-04 | 百码科技(深圳)有限公司 | 一种基因治疗脂肪肝的生物药剂及其制备方法 |
CN113018459A (zh) * | 2021-03-09 | 2021-06-25 | 百码科技(深圳)有限公司 | 一种基因治疗减肥的生物药剂及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
FR2686605B1 (fr) * | 1992-01-27 | 1994-03-11 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides, leur preparation et leur utilisation. |
AU7242394A (en) | 1993-05-28 | 1994-12-20 | Merck & Co., Inc. | Method to control appetite and treat obesity |
US6729075B2 (en) * | 2000-10-19 | 2004-05-04 | Wenger Corporation | Audience seating system |
MXPA04011227A (es) | 2002-05-17 | 2005-01-25 | Esperion Therapeutics Inc | Metodos y composiciones para el tratamiento de la reperfusion isquemica. |
WO2008008357A1 (en) * | 2006-07-11 | 2008-01-17 | Harkness Pharmaceuticals, Inc. | Methods of treating obesity using satiety factors |
US20100267052A1 (en) | 2006-09-01 | 2010-10-21 | American Type Culture Collection | Compositions and methods for diagnosis and treatment of type 2 diabetes |
EP2257814B1 (en) * | 2008-03-21 | 2012-08-29 | Podiceps B.v. | Diagnostic of pre-symptomatic metabolic syndrome |
CN101747305B (zh) | 2008-11-28 | 2014-06-18 | 中国医学科学院药物研究所 | 硝克柳胺化合物晶v型、其制法和其药物组合物与用途 |
ES2558751T3 (es) * | 2010-08-30 | 2016-02-08 | F. Hoffmann-La Roche Ag | Alimento alcalino |
US9051394B2 (en) | 2011-01-19 | 2015-06-09 | University Of Cincinnati | Apolipoprotein AIV as an antidiabetic peptide |
JP6310398B2 (ja) | 2012-01-19 | 2018-04-11 | ユニバーシティ・オブ・シンシナティ | 非グリコシル化アポリポタンパク質a−ivを用いて糖尿病を処置する方法 |
US10232019B2 (en) * | 2012-07-25 | 2019-03-19 | University Of Cincinnati | Method of treating hyperglycemic disorders using apolipoprotein AIV |
US9730980B2 (en) | 2012-07-25 | 2017-08-15 | University Of Cincinnati | Method of treating type I diabetes using apolipoprotein A-IV |
-
2012
- 2012-11-21 JP JP2014553292A patent/JP6310398B2/ja active Active
- 2012-11-21 WO PCT/US2012/066314 patent/WO2013109342A1/en active Application Filing
- 2012-11-21 EA EA201491369A patent/EA028230B1/ru not_active IP Right Cessation
- 2012-11-21 EP EP12795976.5A patent/EP2804618B1/en active Active
- 2012-11-21 US US14/373,259 patent/US9951120B2/en active Active
- 2012-11-21 BR BR112014017141A patent/BR112014017141A2/pt not_active IP Right Cessation
- 2012-11-21 CA CA2860782A patent/CA2860782A1/en not_active Abandoned
- 2012-11-21 KR KR1020147023031A patent/KR20140117565A/ko not_active Application Discontinuation
- 2012-11-21 CN CN201280067554.2A patent/CN104066436B/zh not_active Expired - Fee Related
- 2012-11-21 MX MX2014008829A patent/MX357071B/es active IP Right Grant
- 2012-11-21 AU AU2012366182A patent/AU2012366182B2/en not_active Expired - Fee Related
-
2014
- 2014-06-24 IL IL233351A patent/IL233351A/en active IP Right Grant
-
2015
- 2015-05-06 HK HK15104317.1A patent/HK1203823A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MX2014008829A (es) | 2014-10-24 |
WO2013109342A8 (en) | 2014-09-04 |
US9951120B2 (en) | 2018-04-24 |
EA201491369A1 (ru) | 2015-03-31 |
CN104066436B (zh) | 2016-12-14 |
EA028230B1 (ru) | 2017-10-31 |
KR20140117565A (ko) | 2014-10-07 |
MX357071B (es) | 2018-06-22 |
IL233351A (en) | 2016-12-29 |
CN104066436A (zh) | 2014-09-24 |
EP2804618B1 (en) | 2018-03-07 |
JP6310398B2 (ja) | 2018-04-11 |
IL233351A0 (en) | 2014-08-31 |
BR112014017141A2 (pt) | 2019-09-24 |
CA2860782A1 (en) | 2013-07-25 |
AU2012366182B2 (en) | 2017-08-17 |
US20150011469A1 (en) | 2015-01-08 |
EP2804618A1 (en) | 2014-11-26 |
AU2012366182A8 (en) | 2015-06-18 |
WO2013109342A1 (en) | 2013-07-25 |
JP2015506942A (ja) | 2015-03-05 |
AU2012366182A1 (en) | 2014-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2675459A4 (en) | COMPOUNDS AND METHODS FOR TREATING DIABETES | |
EP2773754A4 (en) | Methods of Treatment | |
GB201110095D0 (en) | Method of treatment | |
HK1203823A1 (en) | Method of treating diabetes using non-glycosylated apolipoprotein a- iv a-iv | |
EP2774966A4 (en) | PHOSPHORUS SURFACE TREATMENT METHOD | |
EP2890391A4 (en) | METHOD AND COMPOSITION FOR TREATING HYPERGLYCEMIA | |
PL2768785T3 (pl) | Sposób obróbki termicznej warstw srebra | |
HK1201439A1 (en) | Method of treating or reducing efp efp | |
HK1259004A1 (zh) | 治療糖尿病的組合物和方法 | |
ZA201403739B (en) | Methods of treatment with deferiprone | |
HK1203370A1 (en) | Method for treatment of labor arrest | |
HK1214355A1 (zh) | 用於治療和/或限制糖尿病發展的方法 | |
EP2816126A4 (en) | THERMAL TREATMENT METHOD | |
GB201108797D0 (en) | Surface treatment method | |
IL228744A0 (en) | A method for treating diseases related to interferon alpha | |
EP2709466A4 (en) | PROCESS FOR TREATING HONEY | |
ZA201407215B (en) | Method for emulsion treatment | |
HK1202819A1 (en) | Treatment of type i and type ii diabetes i ii | |
GB201105523D0 (en) | Treatment method | |
IL238331A0 (en) | A method for treating type I and type II diabetes | |
EP2791324A4 (en) | PROCESSING METHOD | |
AP2014007425A0 (en) | Treatment of sulphidic materials | |
EP2768536A4 (en) | METHOD OF TREATING TYPE I AND TYPE II DIABETES | |
GB201221032D0 (en) | Method of treatment | |
GB201207894D0 (en) | Method of treatment |